Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-Years follow-up

BMC Public Health

Volumn 6, Issue , 2006, Pages

  Vila Córcoles, Angel ^a   Ochoa Gondar, Olga ^a   Ester, Francisco ^a   Sarrá, Nuria ^a   Ansa, Xabier ^a   Saún, Neus ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;

AGED; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG UPTAKE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION RESEARCH; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; STREPTOCOCCUS INFECTION; STROKE; VACCINATION; AGE; CLINICAL TRIAL; ECONOMICS; EVALUATION STUDY; GERIATRIC ASSESSMENT; MULTICENTER STUDY; PATIENT ATTITUDE; PNEUMONIA, PNEUMOCOCCAL; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PROGRAM DEVELOPMENT; REGISTER; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; IMMUNIZATION PROGRAMS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PRIMARY HEALTH CARE; PROGRAM DEVELOPMENT; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; VACCINATION;

EID: 33749471608     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-6-231     Document Type: Article

References (18)

1. Loeb M: Pneumonia in the elderly. Curr Opin Infect Dis 2004, 17(2):127-30.
2. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, Detsky AS, Kapoor WN: Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994, 154:2666-77.
3. Moore RA, Wiffen PJ, Lipsky BA: Are the neumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BCM Family Practice 2000:1.
4. Cornu C, Yzebe D, Leophonte P, Gaillat J, Boissel JP, Cucherat M: Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001, 19:4780-90.
5. Mangtani P, Cutts F, Hall AJ: Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis 2003, 3(2):71-8.
6. Dear K, Holden J, Andrews R, Tatham D: Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003, 4:CD000422.
7. Centers for Disease Control and Prevention: Prevention of pneumococcal disease: Recommendations of the advisory committee on immunisation practices (ACIP). MMWR 1997, 46(RR-08):1-24.
8. Task Force on Community Preventive Service: Recommendations regarding interventions to improve vaccinations coverage in children, adolescents and adults. Am J Prev Med 2000, 18(suppl):92-140.
9. Salleras Ll, Urbitzondo Ll, Fernández N, Comin E, Sanchez F, Batalla J: Pneumococcal vaccine in the elderly population'[in Spanish]. Med Clin (Barc) 2001, 116(1):18-23.
10. Vila A, Ochoa O, Hospital I, Bria X, Llor C, Montañés D, Grupo de Estudio EVAN-65: EVAN-65 project: evaluation of the effectiveness of pneumococcus vaccination in the elderly population over 65.[in Spanish]. Aten Primaria 2004, 33(3):149-53.
11. Daniels NA, Nguyen TT, Gildengorin G, Perez-Stable EJ: Adult immunization in university-based primary care and specialty practices. J Am Geriatr Soc 2004, 52(6):1007-12.
12. Center for Disease Control and Prevention: Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003. MMWR Morb Mortal Wkly Rep 2004, 53(43):1007-12.
13. Christenson B, Hedlund J, Lundbergh P, Ortqvist A: Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004, 23(3):363-8.
14. Andrews R, Counahan M, Hogg G, McIntyre PB: Effectiveness of a publicy funded pneumococcal vaccination program against invasive pneumococcal disease among the elederly in Victoria, Australia. Vaccine 2004, 23:132-138.
15. Melegaro A, Edmunds WJ: The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 2004, 19(4):353-63.
16. Fedson DS, Liss C: Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 2004, 22(8):927-46.
17. Dominguez A, Salleras L, Cardenosa N, Ciruela P, Carmona G, Martinez A, Torner N, Fuentes M: The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study. Vaccine 2002, 20(23-24):2989-94.
18. Nichol KL: The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999, 17(1):S91-3.